Drugs & TargetsFree FDA grants accelerated approval to new dosing regimen for Keytruda May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants Mobocertinib Breakthrough Therapy Designation in NSCLC designation May 01, 2020Vol.46 No.18
FreeIn Brief Kristin Brill named enterprise director of Breast Oncology at SKCC May 01, 2020Vol.46 No.18
FreeIn Brief UCLA researchers receive $2.8M NCI grant to develop blood-based test for liver transplant candidate selection May 01, 2020Vol.46 No.18
COVID-19 UpdatesFree FDA grants Emergency Use Authorization for novel, non-implanted device to wean patients off mechanical ventilation May 01, 2020Vol.46 No.18
COVID-19 UpdatesFree J&J and Emergent Bio collaborate on coronavirus vaccine candidate May 01, 2020Vol.46 No.18
Free Dafna Bar-Sagi, Arul Chinnaiyan, Carl June, Christopher Lima, Miriam Merad, and John Schiller are among newly elected NAS members May 01, 2020Vol.46 No.18
COVID-19 & CancerFreeGuest Editorial Cancer doesn’t wait—we are treating cancer patients now May 01, 2020Vol.46 No.18By Richard Bold and Timothy Donahue
